Microrna expression abnormalities in pancreatic endocrine and acinar tumors

A technology for pancreas and pancreatic cancer, applied in antitumor drugs, medical preparations containing active ingredients, analytical materials, etc., can solve problems such as unpredictability and huge differences in malignant potential.

Inactive Publication Date: 2009-03-11
THE OHIO STATE UNIV RES FOUND
View PDF17 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Malignant potential varies widely between PETs and can

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microrna expression abnormalities in pancreatic endocrine and acinar tumors
  • Microrna expression abnormalities in pancreatic endocrine and acinar tumors
  • Microrna expression abnormalities in pancreatic endocrine and acinar tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0206] Materials and methods

[0207] Patient data, tumor cell enrichment and RNA extraction.

[0208] Table 2 reports the clinicopathological characteristics of 40 PET and 4 PACC obtained from the frozen tissue bank of the Department of Pathology of the University of Verona, Italy. All tumors are sporadic, which is judged by the personal and family history of the patient's direct interview. PET is diagnosed by histopathology and cell marker analysis, and classified according to WHO standards (Kloppel, G. et al., "The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification." Ann. NYAcad. Set 1014: 13-27 ( 2004)). They included 28 non-functional and 12 functional tumors. The 28 NF-PET includes 11 well-differentiated endocrine tumors (WDET) and 18 well-differentiated endocrine carcinomas (WDEC). Twelve F-PETs are insulinomas, which include 11 WDET and 1 WDEC. According to WHO standards that consider tumor size, Ki-67 proliferation index, and vascular...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of pancreatic cancer. The invention also provides methods of identifying anti-pancreatic cancer agent.

Description

[0001] Inventors: Carlo M. Croce and George A. Calin [0002] Government funding [0003] The present invention was funded in whole or in part by project funds P01CA76259 and P01CA81534 from the National Cancer Institute. The government has certain rights in the invention. Background of the invention [0004] Pancreatic cancer can be classified according to where the cancer is found in the pancreas or according to the cell type from which the cancer originated. Pancreatic cancer can occur in the head, body, or tail of the pancreas, and the symptoms can vary with the location of the tumor in the pancreas. 70-80% of pancreatic cancers occur in the head of the pancreas. Most pancreatic cancers are of the exocrine type, and more than 90% of these exocrine pancreatic cancers are adenocarcinomas. They are almost all ductal adenocarcinomas, where the cancer occurs in the cells lining the ducts of the pancreas. In addition, there are more rare types of exocrine pancreatic cancer, such as c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/00C12Q1/58
CPCC12Q2600/178G01N33/57438C12Q1/6886A61N1/30C12Q2600/158C12Q2600/106A61P35/00A61P35/04
Inventor C·M·克罗斯G·A·卡林
Owner THE OHIO STATE UNIV RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap